ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ORGS Orgenesis Inc

0.579
0.036 (6.63%)
Last Updated: 11:29:09
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Orgenesis Inc ORGS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.036 6.63% 0.579 11:29:09
Open Price Low Price High Price Close Price Previous Close
0.547 0.505 0.5796 0.543
more quote information »

Recent News

Date Time Source Heading
4/15/202416:07GLOBEOrgenesis Provides Year End Business Update
4/10/202411:00GLOBEGermfree and Orgenesis Announce Asset Purchase and Strategic..
3/18/202407:30GLOBEVered Caplan, CEO of Orgenesis, to Present at the..
3/13/202407:30GLOBEOrgenesis Consortium Awarded €1.5M EUR Grant from the..
3/04/202407:30GLOBEOrgenesis Inc. Announces $2.3 Million Private Placement
2/29/202407:30GLOBEOrgenesis Consortium Awarded €2.0M EUR Grant from Walloon..
1/31/202408:20EDGAR2Form 8-K - Current report
1/31/202408:15GLOBEOrgenesis Acquires Control of Octomera with the Goal of..
1/24/202415:05EDGAR2Form 8-K - Current report
1/22/202415:01EDGAR2Form 8-K - Current report
1/08/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202416:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/05/202405:02EDGAR2Form 8-K - Current report
11/14/202307:30GLOBEOrgenesis Ranked No. 171st Fastest-Growing Company in North..
11/13/202315:15GLOBEOrgenesis Provides Business Update for the Third Quarter of..
11/09/202306:41EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/08/202308:24EDGAR2Form 8-K - Current report
11/08/202308:00GLOBEOrgenesis Inc. Announces Pricing of $1.1 Million Registered..
11/02/202307:00GLOBEOrgenesis Announces Expanded Partnership Between Octomera..
10/30/202320:30GLOBEOrgenesis Announces Withdrawal of Proposed Public Offering
10/30/202315:07GLOBEOrgenesis Announces Proposed Underwritten Public Offering
9/21/202307:00GLOBECGT Global and Octomera Enter Agreement to Expand Cell &..
9/06/202306:00GLOBECell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard..
9/05/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/11/202306:00GLOBEOrgenesis Provides Business Update for Second Quarter of..
8/10/202316:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202307:30GLOBEOrgenesis Schedules Second Quarter 2023 Business Update..
7/13/202307:30GLOBEOrgenesis Appoints Finance Veteran Elliot Maltz as its Chief..
7/12/202315:05EDGAR2Form 8-K - Current report
7/11/202306:00GLOBEOrgenesis Announces Name Change of Morgenesis Business Unit..
6/07/202306:00GLOBEOrgenesis and University of California, Davis Sign..
5/30/202308:30GLOBEClaudia Zylberberg Appointed as Independent Board Member of..
5/22/202306:30GLOBEOrgenesis Academy Graduates First Class of Cell and Gene..
5/19/202307:30GLOBEOrgenesis to Participate in Benchmark’s 3rd Annual..
5/18/202306:30GLOBEOrgenesis Announces Collaboration Agreement with SCTbio to..
5/10/202315:30GLOBEOrgenesis Provides Business Update for the First Quarter of..
5/10/202309:00GLOBEOrgenesis Secures an Additional $5 Million Investment from..

Your Recent History

Delayed Upgrade Clock